Myriad Genetics · 12 hours ago
Lab Automation Engineer II
322 N 2200 W, Salt Lake City, UT, 84116, US
Full-time
Onsite
Entry, Mid Level
2+ years expMyriad Genetics is a company focused on health technologies, and they are seeking a Lab Automation Engineer II to solve workflow problems in complex health systems. This role involves designing and implementing process automation, working cross-functionally, and contributing to troubleshooting efforts.
BiotechnologyPharmaceuticalPrecision Medicine
No H1B
U.S. Citizen Only
Responsibilities
Design, implement, and test process automation using liquid handlers and other automated equipment
Utilize programming languages to integrate new or modifications to processes to the robotics software stack
Work cross-functionally with the science, lab, manufacturing, and maintenance teams
Design, deploy, and test liquid handler scripts and changes to custom automated work cells
Make impactful contributions to troubleshooting efforts, analyzing data and helping drive key process-related decisions
Develop automation related documentation for effective operation and maintenance of automated equipment
Travel to Myriad locations as needed during certain project phases
Qualification
Required
Bachelor's degree in molecular biology, bioengineering, chemistry, or related field required
2+ years of industry experience
Experience in programming in at least two of the major liquid handling systems (Tecan, Beckman, Hamilton)
Experience with molecular biology lab processes
Software programming experience with Python, C#, or other languages is a plus
Applicant must be a (i) U.S. citizen or national, (ii) U.S. lawful, permanent resident (aka green card holder)
Lifting Requirements – light work or exerting up to 20 pounds of force frequently
Physical Requirements – stationary positioning, moving, operating, ascending/descending, communicating, observing, pushing or pulling, and reaching
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
Company data provided by crunchbase